Filing metadata

Accession number
0001127602-22-012574
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Apr 27, 2022
Reporting period
Apr 21, 2022
Description
Insider transaction

Explore SEC Filings Hub